VEXT — Vext Science Cashflow Statement
0.000.00%
Last trade - 00:00- CA$52.19m
- CA$101.89m
- $35.41m
- 76
- 92
- 62
- 91
Annual cashflow statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.75 | 2.79 | 2.13 | 4.99 | 10.9 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.702 | 0.351 | 1.39 | 3.31 | -0.033 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.74 | -4.64 | -3.07 | -1.74 | -7.18 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 2.41 | -0.393 | 3.1 | 11.7 | 5.92 |
| Capital Expenditures | -1.5 | -5.26 | -4.06 | -18.8 | -8.86 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.08 | -0.147 | -8.84 | -8.31 | -21.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.42 | -5.41 | -12.9 | -27.1 | -30.3 |
| Financing Cash Flow Items | 0.007 | 0.145 | -0.5 | -1.5 | -1.63 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.58 | 9.7 | 4.26 | 20.1 | 23.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.57 | 3.9 | -5.55 | 4.72 | -0.533 |